Article Details

Maze Therapeutics: $115 Million (Series D) Raised To Develop Precision Medicine

Retrieved on: 2024-12-04 06:54:37

Tags for this article:

Click the tags to see associated articles and topics

Maze Therapeutics: $115 Million (Series D) Raised To Develop Precision Medicine. View article details on hiswai:

Excerpt

... Third Rock Ventures, ARCH Venture Partners, Matrix Capital Management, GV, General Catalyst, Andreessen Horowitz (a16z), Foresite Capital ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo